The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
3.5 - 4.0
Mystic Meg looks into her crystal ball and goes ...... no .... today is not your day
I must get me one of these B&M crystal balls
Another 1.1 to go yet
Same reason you are!
Haha ..... they're ain't any news
There is no news..... everybody's guessing .......... incorrectly
There's always news... just what.... and when
hope2gain - Genuine new. I have no interest in ramping / deramping , just interest ,opinion and where you think this share will go , seems I rushed in a bit to keen.
beeshoney - I'm no expert in stocks , shares , funds and will never claim to be.My greatest achievement was buying BLNX @ 38. and getting out @160 some years ago.Today I have a little more spare capital to invest and so bowing to the greater wisdom of your expertise and opinion in this area of the market.Looks like I poked a bear without meaning too , apologies
Crystalball58 - Thanks
gggg21 - thank you
Correct , I don't. I'm looking for info and guidance from people who know better than me
It's freely available info
HaresHopin - None.I joined today as i have a small portfoilio of other stock and just interested in the wider world of investing,clearly you don't need my input as you already have it,apologies,as I said I'm new and came across the info while researching the stock
Assuming clearance is granted, and the studies come back with attractive figures, there is then the question of where GCM is going to get the cash to pay for the project. It is likely that this could dilute its position in Phulbari further, or increase its debt considerably. This would reduce the amount of project value that is returned to investors or used to create value.
GCM must also facilitate the preparation of an environmental impact assessment for Phulbari while PowerChina is yet to carry out its feasibility and viability studies on the project. If the number returned from these studies are weaker than expected then Phulbari could lose much of its current economic appeal and prospective value. In turn, this is what is underpinning GCM’s £28.5m market. In this case, it is not like GCM has another huge project to fall back on.
Meanwhile, the EPC gives PowerChina the exclusive rights for engineering, procurement, and construction of the power plant for an agreed initial cost of $3.5bn. This works out at a $700m contribution from PowerChina and a $2.8bn contribution from GCM. While PowerChina is likely to be able to pay its share, one would assume that it is both business’s best interests to work together in ensuring GCM’s portion can be covered through third-party funding.